Needham maintains Mobileye Global at Buy, lowers price target to $9 from $13

Needham kept its Buy rating on Mobileye Global (MBLY) but cut its price target from $13 to $9, citing a 30.8% decrease. This implies a 40.4% upside from the Oct 29 close of $6.41. Analysts' recent price targets range from $5 to $11.

Original reporting
Published Oct 29, 2026, 9:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 9:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Needham maintains Mobileye Global at Buy, lowers price target to $9 from $13 — source image
Decision brief

The 30-second read

$MBLYNeutralLow
01

Why it matters

A lower price target can influence short-term sentiment and options positioning, but without new company-specific disclosures it is unlikely to drive a major repricing on its own.

02

Market read

Traders may adjust expectations for upside based on the revised target, but the unchanged Buy rating reduces the immediacy of a bearish catalyst.

03

What to watch

The article provides no new Mobileye operational data, so the PT change may reflect model assumptions rather than deteriorating fundamentals.

Relevance 4/10Novelty 4/10Timing: after-hours/next-session positioning based on analyst PT change

Background

The piece summarizes an analyst note from Needham on Mobileye Global, focusing on rating maintenance and a reduced price target.

Company-level read

Ticker impact

$MBLYNeutralMedium confidence
Context

Needham maintained Mobileye Global at Buy but cut its price target to $9 from $13, implying a lower valuation outlook.

Expected impact

Likely mild downward pressure or reduced upside as traders price in the lower target, with limited follow-through risk given the rating is unchanged.

Evidence & confidence

The article is an analyst PT cut without new company fundamentals; such updates often influence sentiment more than fundamentals, especially when the rating remains Buy.

Market effects

Marginal read-through to autonomous-driving/ADAS sentiment, but no sector-wide catalyst is provided.

No specific regional market linkage beyond US-listed analyst coverage.

Limited global relevance; this is a single-name valuation adjustment.

Counterpoint

Because the rating is maintained at Buy, the PT cut may be viewed as a valuation reset rather than a thesis break, limiting downside follow-through.

Key entities

  • Mobileye Global

    Subject of the analyst action: Buy rating maintained, price target lowered to $9 from $13.

Related articles

$MBLYHighAI 8/10

Mobileye Q3 FY2026 Revenue Edges Down 2% YoY to $492 Million

Mobileye (MBLY) reported Q3 FY2026 revenue of $492M, down 2% YoY. Operating loss narrowed 25%, adjusted profit rose 20%. CEO cited growth from ADAS tech adoption. Chip shipments rose 11% YoY despite auto market weakness. Full-year revenue guidance raised to $1.995B-$2.02B. New ADAS design wins and robotaxi services announced.

$RDDTHighAI 8/10

Why Did RDDT, IREN, MBLY Stocks Tumble To 52-Week Lows Last Week?

Reddit (RDDT) stock fell 29% to a 52-week low of $89.28 despite strong Q3 earnings, due to a drop in Google search referrals. IREN (IREN) shares declined 8% to $23.06 amid concerns over high borrowing costs. Mobileye (MBLY) dropped 7% after a downgrade to 'Hold' due to product delays. KeyBanc downgraded RDDT, while B. Riley cut IREN's price target but maintained a 'Buy' rating.

$MBLYMed

Piper Sandler reiterates Mobileye stock rating at overweight

Piper Sandler maintained an Overweight rating and $12.00 price target for Mobileye (MBLY) after its Q3 results beat expectations. The company's 2026 guidance increased but less than anticipated. Mobileye's stock is down 51% year-over-year, trading at $6.41. Piper Sandler noted risks like Chinese competition but expects higher-value ADAS sales to benefit Mobileye's P&L starting 2027. TD Cowen downgraded MBLY to Hold with a $7.00 price target, citing delays and partner challenges.